medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2008, Number 3

<< Back Next >>

Rev Invest Clin 2008; 60 (3)

Laparoscopic vs. open total mesorectal excision for treatment of rectal cancer

González QH, Rodríguez-Zentner HA, Moreno-Berber JM, Vergara-Fernández O, Tapia-Cid de León H, López-R F, Jonguitud LA, Ramos R, Castañeda-Argáiz R

Language: English
References: 39
Page: 205-211
PDF size: 67.83 Kb.


ABSTRACT

Introduction. Because definitive long-term results are not yet available, the oncologic safety of laparoscopic surgery in rectal cancer remains controversial. Laparoscopic total mesorectal excision (LTME) for rectal cancer has been proposed to have several short-term advantages in comparison with open total mesorectal excision (OTME). However, few prospective randomized studies have been performed. Objectives. The main purpose was to evaluate whether there are relevant differences in safety and efficacy after elective LTME for the treatment of rectal cancer compared with OTME in a tertiary academic medical center. Material and methods. This comparative non-randomized prospective study analyzes data of 20 patients with middle and low rectal cancer treated with low anterior resection (LAR) or abdomino perineal resection (APR) from November 2005 to April 2006. Follow-up was determined through office charts or direct patient contact. Statistical analysis was performed using χ2 test and Student’s t-test. Results. Ten patients underwent LTME and 10 patients underwent OTME. No conversion was required in the LTME group. Mean operating time was shorter in the laparoscopic group (LTME) (186.7 vs. 204.4 min, p ‹ 0.007). Less intraoperative blood loss and fewer postoperative complications were seen in the LTME group. An earlier return of bowel motility was achieved after laparoscopic surgery. There was no 30-day mortality and the overall morbidity was 20% in the LTME group vs. 40% in the OTME group. The mean number of harvested lymph nodes was greater in the laparoscopic group than in OTME group (10.2 ± 2.5 vs. 8.3 ± 3). Mean follow-up time was 12 months (range 9-15 months). No local recurrence was found. Conclusion. LTME is a feasible procedure with acceptable postoperative morbidity and low mortality, however it is technically demanding. This series confirms its safety, while oncologic results are at present comparable to the OTME published series, with limitation of a short follow-up period though. Further randomized studies are necessary to evaluate long-term clinical outcome.


REFERENCES

  1. Leung KL, Kwok SPY, Lam SC, Lee JF, Yiu RY, Ng SS, et al. Laparoscopic resection of rectosigmoid cancer: prospective randomized trial. Lancet 2004; 363: 1187-92.

  2. Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908; 2: 1812-3.

  3. Ridgway PF, Darzi AW. The Role of Total Mesorectal Excision in the management of Rectal Cancer. Cancer Control 2003; 102: 205-11.

  4. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-9.

  5. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer – results of a prospective randomized trial. N Engl J Med 1984; 310: 737-43.

  6. Gastrointestinal Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985; 312: 1465-72.

  7. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br J Surg 1982; 69: 613-6.

  8. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlene JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-9.

  9. Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004; 350: 2050-9.

  10. Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, Visa J. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomized trial. Lancet 2002; 359: 2224-9.

  11. Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991; 1: 144-50.

  12. Ramos JR, Petrosemolo RH, Valory EA, Polania FC, Pecanha R. Abdominoperineal resection: laparoscopic versus conventional. Surg Laparosc Endosc 1997; 7: 148-52.

  13. Fleshman JW, Wexner SD, Anvari M, LaTulippe JF, Birnbaum EH, Kodner IJ, et al. Laparoscopic vs. Open abdominoperineal resection for cancer. Dis Colon Rectum 1999; 42: 930-9.

  14. Lavery IC, Lopez-Kostner F, Pelley RJ, Fine RM. Treatment of colon and rectal cancer. Surg Clin North Am 2000; 80: 535-69.

  15. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Dutch Colorectal Cancer Group, et al. Preoperative radiotherapy combined with local mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-46.

  16. Quah HM, Jayne DG, Eu KW, Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2002; 89: 1551-6.

  17. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-46.

  18. Enker WE. Total mesorectal excision-the new golden standard of surgery for rectal cancer. Ann Med 1997; 29: 127-33.

  19. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio VW. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 1998; 124: 612-7.

  20. Karanjia ND, Corder AP, Bearn P, Heald RJ. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 1994; 81: 1224-6.

  21. Nymann T, Jess P, Christiansen J. Rate and treatment of pelvic recurrence after abdominoperineal resection and low anterior resection for rectal cancer. Dis Colon Rectum 1995; 38: 799-802.

  22. Morino M, Parini U, Giraudo G, Salval M, Brachet Contul R, Garrone C. Laparoscopic total mesorectal excision: a consecutive series of 100 patients. Ann Surg 2003; 237: 335-42.

  23. Hartley JE, Mehigan BJ, Qureshi AE, Duthie GS, Lee PW, Monson JR. Total mesorectal excision: assessment of the laparoscopic approach. Dis Colon Rectum 2001; 44: 315-21.

  24. Larach SW, Salomon MC, Williamson PR, Goldstein E. Laparoscopic assisted abdominoperineal resection. Surg Laparosc Endosc 1993; 3: 115-8.

  25. Darzi A, Lewis C, Menzies-Gow N, Guillou PJ, Monson JR. Laparoscopic abdominoperineal excision of the rectum. Surg Endosc 1995; 9: 414-7.

  26. Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998; 85: 526-9.

  27. Wai Lun Law, Kin Wah Chu. Anterior Resection for Rectal Cancer with mesorectal excision. A prospective evaluation of 622 patients. Ann Surg 2004; 240: 260-8.

  28. Griffen FD, Knight CD Sr, Whitaker JM, Knight CD Jr. The double stapling technique for low anterior resection: results, modifications and observations. Ann Surg 1990; 211: 745-51.

  29. Leroy J, Jamili F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long term outcomes. Surg Endosc 2004; 18: 281-9.

  30. McAnena OJ, Heald RJ, Lockhart-Mummery HE. Operative and functional results of total mesorectal excision with ultralow anterior resection in the management of carcinoma of the lower one-third of the rectum. Surg Gynecol Obstet 1990; 170: 517-21.

  31. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and ultimate survival. BMJ 1991; 302: 1501-5.

  32. Fazio VW, Lopez-Kostner F. Role of laparoscopic surgery for treatment of early colorectal carcinoma. World J Surg 2000; 24: 1056-60.

  33. Braga M, Vignali A, Gianotti L, Zuliani W, Radaelli G, Gruarin P, et al. Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 2002; 236: 759-67.

  34. Champault GG, Barrat C, Raselli R, Elizalde A, Catheline JM. Laparoscopic versus open surgery for colorectal carcinoma: a prospective clinical trial involving 157 cases with a mean follow- up of 5 years. Surg Laparosc Endosc Percut Tech 2002; 12: 88-95.

  35. Hong D, Tabet J, Anvari M. Laparoscopic vs open resection for colorectal adenocarcinoma. Dis Colon Rectum 2001; 44: 10-9.

  36. Milsom JW, Bohm B, Hammerhofer KA, Fazio V, Steiger E, Elson P. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg 1998; 187: 46-55.

  37. Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G, Clinical Outcomes of Surgical Therapy (COST) Study Group. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. J Am Med Assoc 2002; 287: 321-8.

  38. Rubino F, Leroy J, Marescaux J. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 2003; 90: 48.

  39. AJCC Cancer Staging Manual. 5th Ed. Philadelphia, PA: Lippincott- Raven; 1998.




2020     |     www.medigraphic.com